|

Actinium Ac 225-DOTA-anti-CEA Monoclonal Antibody M5A Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 225Ac-DOTA-M5A Humanized Anti-CEA Antibody, 225Ac-DOTA-anti-CEA Monoclonal Antibody M5A

Pipeline

Phase 1: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Advanced Cancer1
  • Metastatic Cancer1
  • Cancer1

Duarte, California1 trial

Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.